The MMS Experience

We are one team with one purpose – to positively improve lives worldwide.

At MMS, regardless of where our colleagues are located around the world, we are one team with one purpose – to positively improve lives worldwide. #OneMMS is more than just a hashtag. It’s a promise that our organization embraces the unique strengths and experiences of colleagues, providing everyone the opportunity to fortify and grow their talents, as well as enjoy dynamic career opportunities in life sciences.

DIVERSITY

Our global footprint provides MMS colleagues the opportunity to experience many different cultures and backgrounds, resulting in a work environment focused on inclusion and mutual respect. We celebrate and continuously welcome diversity to our team, and we keep diversity, equity, and inclusion (DEI) top of mind as we build global engagement activities, implement new processes, and innovative technology, open new positions, and offer new leadership opportunities.

TEAMWORK

We are committed to helping our colleagues achieve a common goal – making a positive impact on patients’ lives and the lives of their families. For each project we undertake, our team promotes flexible planning to assess subject matter expertise, process optimization, and risk planning for any project to ensure on-time delivery and added value to each client.

FLEXIBILITY & ADAPTABILITY

Our innovation-first, Kaizen culture allows us to embrace change, pioneer new processes and technologies, and work on continual improvement in every aspect of our business. Colleagues, at any level in our organization can propose improvements and see their suggestions come to fruition with our culture of continual, proven improvement.

OUR CLIENTS

Working at MMS gives our global colleagues a unique opportunity to work with a variety of industry-leading clients, therapeutic areas, drug development phases, and projects in the pharmaceutical, biotechnology, and medical device industries. Our extensive training, leadership, and mentor programs give colleagues from all backgrounds and experience levels the opportunity to learn.

Suggested For You

perspectives

January 21st, 2025

REMS Modifications and Revisions: A Retrospective from the Past 12 Months

regulatory intelligence

January 17th, 2025

The FDA’s AI Guidance and its Seven Steps into the Future of Drug Development

regulatory intelligence

January 17th, 2025

New FDA Protocol Deviation Guidance:  Planning for the Things That Don’t Go According to Plan

perspectives

January 9th, 2025

How to Create Efficiencies When Creating Simultaneous NDA and MAA Submissions for the FDA and EMA

perspectives

January 2nd, 2025

Informed Consent in Clinical Research: Understanding its Significance and Sponsor Obligations

perspectives

December 17th, 2024

Oncology Drug Development: Webinar Learnings on the Use of Expedited Pathways and Oncology Center of Excellence Programs

perspectives

December 11th, 2024

Why Emerging Biotech Companies are Increasingly Turning to Specialized Data CROs

regulatory intelligence

December 4th, 2024

FDA Issues Detailed Guidance on Development of Gene Therapy Products

news

December 4th, 2024

AI in Pharma and Innovative Leadership Were on Display at the Biennial MMS Scientific Symposium

perspectives

November 26th, 2024

Finding GRASEland: Navigating the New Regulatory Path for Grandfathered OTC Drugs 

perspectives

November 21st, 2024

Essential Nonclinical Strategies for Cell and Gene Therapy (CGT) Success

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year